Bionano Genomics Files 8-K for Material Agreement
Ticker: BNGO · Form: 8-K · Filed: Feb 21, 2025 · CIK: 1411690
| Field | Detail |
|---|---|
| Company | Bionano Genomics, Inc. (BNGO) |
| Form Type | 8-K |
| Filed Date | Feb 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
Related Tickers: BNGO
TL;DR
Bionano Genomics (BNGO) filed an 8-K on Feb 21, 2025, reporting a material definitive agreement.
AI Summary
On February 21, 2025, Bionano Genomics, Inc. filed an 8-K report detailing a material definitive agreement and financial statements. The company, incorporated in Delaware with its principal executive offices in San Diego, CA, operates in the laboratory analytical instruments sector.
Why It Matters
This filing indicates a significant contractual development for Bionano Genomics, Inc., which could impact its operations and financial standing.
Risk Assessment
Risk Level: low — The filing is a standard disclosure of a material agreement and financial information, not indicating immediate operational or financial distress.
Key Numbers
- 001-38613 — SEC File Number (Identifies the company's filing with the SEC.)
- 26-1756290 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Bionano Genomics, Inc. (company) — Registrant
- February 21, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- San Diego, CA (location) — Principal Executive Offices
- 3826 (sic_code) — Standard Industrial Classification
FAQ
What type of material definitive agreement was entered into by Bionano Genomics, Inc.?
The filing does not specify the exact nature of the material definitive agreement, only that one was entered into on or before February 21, 2025.
What is the SIC code for Bionano Genomics, Inc.?
The Standard Industrial Classification (SIC) code for Bionano Genomics, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.
When was Bionano Genomics, Inc. incorporated?
Bionano Genomics, Inc. was incorporated in Delaware.
What is the address of Bionano Genomics, Inc.'s principal executive offices?
The principal executive offices of Bionano Genomics, Inc. are located at 9540 Towne Centre Drive, Suite 100, San Diego, California 92121.
What is the filing date of this 8-K report?
The 8-K report was filed on February 21, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 21, 2025 regarding Bionano Genomics, Inc. (BNGO).